Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

Sage is lopping off one-third of its workforce after one of its experimental drugs failed to prove effective as a treatment ...

Posterial Cortical Atrophy, sometimes called Benson’s disease, is a rare degenerative brain condition that affects the back ...

While lecanemab is approved for use in USA, Japan, China, South Korea and Israel, the European Medicines Agency (EMA) refused ...

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...

22, 2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight ... Jan. 24, 2024 — New research ...

Prothena Corporation plc's stock has dropped 67% since my last “Buy” rating, primarily due to delays and a lack of meaningful ...

Dementia Australia has expressed disappointment at the decision to reject for use in Australia a new drug claimed to slow the ...

Researchers are investigating whether drugs currently used for diabetes and eye diseases could help to prevent or treat ...

Potomac-based IGC Pharma Inc. Thursday announced enrollment of patients at the Baycrest Academy for Research and Education in ...

One of the raw materials studied by the group is cashew nut shell liquid, a by-product of oilseed processing; work was ...

Sage Therapeutics Inc.'s stock slid 4.7% Thursday, after the biotech said it's cutting about 33% of its workforce as part of an overhaul of its business and pipeline that's expected to extend its cash ...